India is the world's largest consumer of antibiotics — and it is paying a devastating price. Antimicrobial resistance (AMR) now kills an estimated 58,000 newborns in India every year, and carbapenem-resistant organisms are increasingly found in community settings, not just ICUs. For the OPD doctor, this is not a distant policy problem. It is something being shaped — and potentially solved — prescription by prescription, patient by patient. Why the OPD Doctor Is the Last Line of Defence Over 80% of antibiotics in India are prescribed in outpatient settings — not hospitals. That means private GPs, family physicians, and specialists in clinics are where AMR is won or lost. The pressure is real: patients demand antibiotics for viral URTIs, parents insist on 'strong medicines' for their child's fever, and pharmacies dispense without prescriptions. Understanding the clinical and systemic pressure points is the first step to practising smarter. India's Worst Resistance Patterns in 2026 The ICMR's AMR surveillance network has flagged the following organisms as critical concerns for Indian clinicians: Klebsiella pneumoniae (ESBL & CRE) Extended-spectrum beta-lactamase (ESBL)-producing Klebsiella is now endemic in India. Carbapenem-resistant Enterobacteriaceae (CRE) strains are no longer limited to tertiary ICUs — they are appearing in community-acquired UTIs and wound infections. Carbapenems must be reserved as last resort, and empirical third-generation cephalosporins are increasingly ineffective for UTIs in patients with prior antibiotic exposure. Staphylococcus aureus (MRSA) Community-acquired MRSA (CA-MRSA) skin and soft tissue infections are rising. Cloxacillin is no longer reliably effective. Cotrimoxazole, doxycycline, or clindamycin are now first-line choices for mild CA-MRSA SSTIs, while vancomycin and linezolid remain reserved for severe cases. 5 OPD Stewardship Rules Every Indian Doctor Should Follow Rule 1 — Do Not Prescribe Antibiotics for Viral URTI The common cold, most sore throats, and the majority of acute coughs are viral. The Centor score is a useful 2-minute clinical tool for streptococcal pharyngitis — score 0-1 requires no antibiotic, score 4+ warrants treatment. Communicate this to patients explicitly: 'This is a viral infection. Antibiotics will not help and will make future infections harder to treat.' Rule 2 — Use Narrow-Spectrum First For uncomplicated community-acquired pneumonia in a non-hospitalised patient without comorbidities, amoxicillin remains effective in most regions. Reserve azithromycin for atypical cover when clinically indicated. Fluoroquinolones should not be first-line for uncomplicated RTIs — their overuse is driving resistance in E. coli urinary isolates across India. Rule 3 — Always Specify Duration Vague prescriptions like 'take for a few days' are a major stewardship failure. Shorter courses are now evidence-backed for many infections: 5 days for uncomplicated CAP, 3-5 days for uncomplicated UTI in women, 5 days for acute sinusitis that does require antibiotics. Write the exact duration and communicate why stopping on time matters. Rule 4 — Order a Culture Before Starting Empirical Treatment Where Feasible For recurrent UTIs, wound infections, and any case that has failed a prior antibiotic course, send a culture and sensitivity before starting empirical treatment. India's local antibiograms often differ dramatically from international guidelines. Clinics that track their own culture data make far better prescribing decisions. Rule 5 — Resist Patient Pressure with Evidence-Based Communication Studies show that patients who receive a clear explanation of why antibiotics are not needed are just as satisfied as those who receive a prescription. Offer a 'safety net' plan: 'Come back in 72 hours if the fever is not settling or symptoms worsen.' This builds trust and reduces unnecessary dispensing. Frequently Asked Questions: Antibiotic Stewardship for Indian Doctors Q: Is amoxicillin-clavulanate still the right choice for acute otitis media in children in India? For children aged 2 and above with non-severe AOM and no history of recurrent infections, watchful waiting for 48-72 hours is appropriate if the family can be reliably contacted. If antibiotics are indicated, amoxicillin remains first-line. Amoxicillin-clavulanate is reserved for cases with concurrent conjunctivitis, failure to respond to amoxicillin, or prior frequent antibiotic use. Q: My patient has a UTI. Urine culture shows ESBL E. coli resistant to co-amoxiclav and cephalosporins. What are my outpatient options? For uncomplicated lower UTI caused by ESBL E. coli, fosfomycin (3g single dose) is an effective oral option with generally preserved susceptibility. Nitrofurantoin remains active against most ESBL organisms and is appropriate for lower UTIs without upper tract involvement. Avoid oral carbapenems — ertapenem IV is reserved for complicated cases requiring hospitalisation. Q: How do I handle the patient who demands antibiotics and threatens to go to another doctor if I don't prescribe? This is the hardest stewardship challenge in Indian practice. Document your clinical reasoning in the patient notes. Explain that prescribing an antibiotic that is not needed is a medical decision — not a service. Offer symptomatic treatment, a written follow-up plan, and your contact in case of deterioration. Most patients, when treated with respect and explanation, do not escalate. Q: Does prescribing a probiotic alongside antibiotics help reduce resistance selection? Probiotics do not reduce antibiotic resistance selection, but they are evidence-backed for reducing antibiotic-associated diarrhoea, particularly Lactobacillus rhamnosus GG and Saccharomyces boulardii. They are a reasonable add-on for patients on broad-spectrum antibiotics, especially children and the elderly, but should not be used as a marketing tool to make patients feel better about unnecessary antibiotic prescriptions. How Doctrust Helps Indian Doctors Prescribe Smarter Doctrust integrates drug interaction alerts, local antibiogram insights, and evidence-based prescribing guides directly into your clinical workflow. Our platform helps Indian doctors track prescription patterns, flag potential resistance risks at the point of care, and access the latest ICMR guidelines without leaving the consultation screen. If you want to practise smarter antibiotic stewardship while reducing the administrative burden on your clinic, get a free demo today at www.doctrust.in